contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-presentation-including-qanda-session-of-qlucores-interim-report-for-the-period-1-may-2025-31-january-2026

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

Qlucore

Qlucore’s interim report for the period 1 May 2025 – 31 January 2026 will be published 26 February 2026.Qlucore invites you to a video conference where the interim report will be presented by...

<div class="mfn-preamble"><p><strong>Qlucore’s interim report for the period 1 May 2025 – 31 January 2026 will be published 26 February 2026.</strong></p></div><div class="mfn-body"><p>Qlucore invites you to a video conference where the interim report will be presented by the CEO. There will be a Q&amp;A session after the presentation. The presentation will be in Swedish. Questions can be asked in English.<br><br><strong>Date:</strong> Thursday 26th of February at 10.30 am CET.<br><br><strong>Meeting link (Teams): </strong><strong><a rel="noopener" href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjJlMzY1ZmYtZjExYy00MzA3LTkxMjYtOTdiMWI4OTM0MjA0%40thread.v2/0?context=%7b%22Tid%22%3a%2298d8b974-7f8e-4878-b589-97db8a2efd27%22%2c%22Oid%22%3a%22431f332f-5978-43c1-9673-dce157e01218%22%7d">Connect</a></strong></p></div><div class="mfn-footer mfn-fecabf0ff01e"><p><strong class="mfn-heading-1">Certified Advisor</strong></p><hr><p>FNCA Sweden AB<br>Web: <a rel="noopener" href="http://www.fnca.se">www.fnca.se</a></p></div><div class="mfn-footer mfn-contacts mfn-8d797af6b758"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Carl-Johan Ivarsson, CEO<br>Phone: +46 (0) 46 286 31 10<br>Email:&nbsp;<a rel="noopener" href="mailto:carl-johan.ivarsson@qlucore.com">carl-johan.ivarsson@qlucore.com</a>&nbsp;<br></p></div><div class="mfn-footer mfn-about mfn-f7eb3615730a"><p><strong class="mfn-heading-1">About Qlucore</strong></p><hr><p>Qlucore develops AI‑based software that enables more accurate diagnostics and a more cost‑efficient healthcare system. Through the company’s precision medicine solutions, tens of thousands of genetic data points are transformed into clear decision‑making support, making it possible to deliver the right treatment to each patient at the right time.</p><p>The first diagnostic test – for pediatric blood cancer – has been approved for sale within the EU. Additional tests, including for lung cancer, adult blood cancer, and bladder cancer, are under development. These products target large and growing markets with significant medical and economic needs. The goal is to improve treatment outcomes, reduce human suffering, and lower healthcare costs.</p><p>In addition to its diagnostics portfolio, Qlucore offers Qlucore Omics Explorer, an established software platform for advanced data analysis used by researchers and pharmaceutical companies worldwide. The company has customers in about 20 countries, sales offices in Europe and North America, and distributors across several Asian markets.</p><p>Qlucore is listed on Nasdaq First North Growth market. More information: <a rel="noopener" href="http://www.qlucore.com/">www.qlucore.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/cc63cfbd-c2c4-4b88-a120-84be5cf8ab86/invitation-to-presentation-including-qanda-session-of-qlucores-interim-report-for-the-period-1-may-2025-31-january-2026.pdf" class="mfn-generated mfn-primary">Invitation to presentation including Q&amp;A session of Qlucore’s interim report for the period 1 May 2025 – 31 January 2026</a></p></div>

Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May 2025 – 31 January 2026

Finanslingo enkelt förklarat: EBIT, EBITA och EBITDA 

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Return on capital (ROE, ROI, ROIC, RONIC)

Vad betyder ATH?

Dollarns dominans – ohotad eller sårbar?  Om dollarns position som världsvaluta 